| AS20000032 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | New Drug Application | 2000-10-31 | 安万特（中国）投资有限公司 | Sanofi (China) Investment Co Ltd | Approval Completed-Pending Certificated | | view |
| CYSB2400237 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2024-09-13 | | Zhuhai United Laboratories Co Ltd | | | view |
| CYSB2101051 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2021-04-27 | | Gan & Lee Pharmaceuticals | | | view |
| CYSB2300078 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2023-04-05 | | Gan & Lee Pharmaceuticals | | | view |
| CYSB2200127 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products(3.3) | Supplementary Application | 2022-06-02 | | Yichang HEC Changjiang Pharmaceutical Co Ltd | | | view |
| CYSB2300211 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2023-11-22 | | Sanofi (Beijing) Pharmaceuticals Co Ltd | | | view |
| CYSB2101251 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2021-11-03 | | Sanofi (Beijing) Pharmaceuticals Co Ltd | | | view |
| CYSB2400113 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products(3.3) | Supplementary Application | 2024-05-14 | | Wanbang Biopharmaceuticals | | | view |
| CYSB2200161 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2022-06-29 | | Sanofi (Beijing) Pharmaceuticals Co Ltd | | | view |
| JYSZ2400051 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | License Renew | 2024-09-04 | | | | | view |
| CXSB2101014 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2021-05-21 | | Gan & Lee Pharmaceuticals | | | view |
| JYSZ2300012 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | License Renew | 2023-02-28 | | | | | view |
| CYSB2200117 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2022-05-18 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
| CYSB2300212 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2023-11-22 | | Sanofi (Beijing) Pharmaceuticals Co Ltd | | | view |
| JYSB2400080 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2024-04-08 | | | | | view |
| JYSB2101151 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2021-10-21 | | Sanofi-Aventis Deutschland GmbH | | | view |
| CYSB2200118 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2022-05-18 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
| CYSB2400224 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2024-08-29 | | Gan & Lee Pharmaceuticals | | | view |
| JYSB2101083 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2021-07-08 | | Sanofi-Aventis Deutschland GmbH | | | view |
| JYSZ2300013 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | License Renew | 2023-02-28 | | | | | view |
